[1] Hashizume H,Sato K,Yamazaki Y,et al. A prospective study of long-term outcomes in female patients with nonalcoholic steatohepatitis using age-and body mass index-matched cohorts. Acta Med Okayama,2013,67(1):45-53. [2] Matteoni C,Younossi Z,Gramlich T,et al. Nonalcoholic fatty liver disease:a spectrum of clinical and pathological severity. Gastroenterology,1999,116(6):1413-1419. [3] Dunn W,Xu R,Wingard D,et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol,2008,103(9):2263-2271. [4] Targher G,Day C,Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med,2010,363(14):1341-1350. [5] Villanova N,Moscatiello S,Ramilli S,et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology,2005,42(2):473-480. [6] 何清,何奔. 非酒精性脂肪性肝病与动脉粥样硬化. 中华心血管病杂志,2010,38(6):571-573. [7] Neuschwander-Tetri B. Nonalcoholic steatohepatitis and the metabolic syndrome. Am J Med Sci,2005,330(6):326-35. [8] 范建高. 代谢综合征与脂肪肝. 国外医学(内分泌学分册),2002,22(5):273-275. [9] 丁雯瑾, 范建高. 世界胃肠病组织非酒精性脂肪性肝病诊疗指南简介. 实用肝脏病杂志,2014,17(5):561-564. [10] Schoenenberger A,Urbanek N,Bergner M,et al. Associations of reactive hyperemia index and intravascular ultrasound-assessed coronary plaque morphology in patients with coronary artery disease. Am J Cardiol,2012,109(12):1711-1716. [11] Heitzer T,Schlinzig T,Krohn K,et al. Endothelial dysfunction, oxidative stress,and risk of cardiovascular events in patients with coronary artery disease. Circulation,2001,104(22):2673-2678. [12] Rivera R,Vanaclocha F. Nonalcoholic fatty liver disease and psoriasis. Actas Dermo-Sigiliograficas,2010,101(8):657-658. [13] Ashburn D,Reed M. Gastrointestinal system and obesity. Crit Care Clin,2010,26(4):625-627. [14] Roitberg G,Sharkhun O,Ushakova T. Non-alcoholic fatty liver disease as an atherosclerosis risk factor. Eksp Klin Gastroenterol,2010,23(7):20-24. [15] 胡晨波,李仲平,潘洁萍,等. 非酒精性脂肪性肝病痰瘀证与颈动脉内膜中层厚度的关系探讨. 实用肝脏病杂志,2015,18(1):38-42. [16] 高鑫. 非酒精性脂肪性肝病与代谢综合征. 中国实用内科杂志,2011,9(2):73-79. [17] Las G,Shirihai O. The role of autophagy in beta-cell lipotoxicity and type 2 diabetes. Diabetes Obes Metab,2010,12(Suppl 2): 15-19. [18] Wang Z,Nakayama T. Inflammation,a link between obesity and cardiovascular disease. Mediators Inflamm,2010,2010:535918. [19] de Ferranti S,Mozaffarian D. The perfect storm:obesity,adipocyte dysfunction,and metabolic consequences. Clin Chem,2008,54(6):945-955. [20] Bakhai A. Adipokines-targeting a root cause of cardiometabolic risk. QJM,2008,101(10):767. |